SPONDİLOARTROPATİLERİN TEMEL ÖZELLİKLERİ VE AYIRICI TANI VE TEDAVİSİNİN GENEL KRİTERLERİ

Year 2001, Volume: 2 Issue: 2, 31 - 35, 01.08.2001

Ö. Faruk Şendur Ali Aydeniz

Abstract

-

Keywords

Spondiloartropatiler

Spondyloarthropathies Basic Features, Principles of Diagnosis And Treatment

Abstract

Spondyloarthropathies are characterised by inflammation of vertebrae, peripheral joints and periarticular tissues. Diseases in this group present with similar clinical features. Etiology is unknown but genetical tendency, infectious agents and environmental factors may play a role. In this review main features and new approaches in treatment of spondyloarthropathies are briefly overviewed.

Keywords

Spondyloarthropathies

References

• 1. Arasýl T. Ankilozan Spondilit;Beyazova M, Kutsal Y.G. (ed.ler). Fiziksel týp ve rehabilitasyon. Ankara: Güneþ Kitabevi, 2000:1577-91.
• 2. Kabasakal Y. Spondiloartritler; Gümüþdiþ G, Doðanavþargil E. (ed.ler). Klinik romatoloji. Ýstanbul: Deniz Matbaasý, 1999: 441-65.
• 3. Koehler L, Kuipers JG, Zeidler H. Managing seronegative spondyloarthritis. Rheumatology 2000; 39:360-8.
• 4. Brown MA, Jepson A, Young A,et al. Ankylosing spondylitis in West Africans: Evidence for a non-HLAB27 protective effect. Ann Rheum Dis. 1997; 56:68-70.
• 5. L a u C S , Va r g a s RB , L a ut h r e n o o W, et al . Spondyloarthropathies,rheumatic diseases. Clin North Am 1998;24:753-70.
• 6. Nasution AR, Mardjuadi A, Kunmartini S, Suryadhana NG,et al. HLA-B27 subtypes positively and negatively associated with spondyloarthropathy. J Rheumatol 1997;24:1111-4.
• 7. Aho K, Leirisalo-Repo M, Repo H. Reactive arthritis. Clin Rheum Dis 1985;11:25-40.
• 8. Kuiper JG, Koehler L, Zeidler H. Reactive or infectious arthritis. Ann Rheum Dis 1999; 58:661-4.
• 9. Cush JJ, Lipsky PE. The spondyloarthropathies. In: Bennett JC, Plum F.(ed.s) Cecil textbook of medicine, 20 ed. Philadelphia, WB Saunders Company, 1996: 1466-72.
• 10. Schumacher HR, Bardin T. Spondyloarthropathies. Classification and diagnosis. Do we need new terminologies. Baillers Clin Rheumatol 1998;12: 551- 65.
• 11. Zeidler H, Mau W, Khan MA. Undifferentiated spondyloarthropathies. Rheum Clin North Am 1992;18:187-202.
• 12. Dougados M, Van der Linden S, Juhlin R, et al. The European spondyloarthropathy study group preliminary criteria for the classification of spondyloarhtropathies. Arthritis and Rheumatism 1991; 34:1218-27.
• 13. Amor B,Dougados M,Listrat V,et al. Are classification criteria for spondyloarthropathy usefull as a diagnostic criteria? Rev Rheum 1995; 6:10-15.
• 14. Coolantes-Asteves E, Cisnal del Mazo A, MunozGomarez E. Assesment of 2 systems of spondyloarthropathy diagnostic and classification criteria (Amor and ESSG) by Spanish multicenter study. J Rheumatol 1995; 22:246-51.
• 15. Leirasolo-Repo M. Therapeutic aspects of spondyloarthropathies. Scand J Rheumatol 1998; 27:323-8.
• 16. D o u g a d o s M , R e v a l M , K h a n M A . Spondyloarthropathy treatment: Progress in medical treatment, physical therapy and rehabilitation. Baillers Clin Rheumatol 1998;12:717-36.
• 17. Lau CS, Vargas RB, Louthrenoo W,et al. Spondyloarthropathies. Rheumatic diseases. Clin North Am 1998; 24:753-70.
• 18. Creemers MCW, van Riel PL, Franssen MJ,van de Putte LB,Gribnau FW. Second-line treatment in seronegative spondyloarthropathies. Semin Arthritis Rheum 1994; 24:71-81.
• 19. Toivanen A, Yli-Kerttula T, Luukkainen R, et al. Effect of antimicrobial treatment on chronic reactive arthritis. Clin Exp Rheumatol 1993; 11:301-7.
• 20. Egsmose C, Hansen TM, Andersen LS, et al. Limited effect of sulphasalazine treatment in reactive arthritis. Ann Rheum Dis 1997;56:32-6.
• 21. Shih LY,Chen TH,Lo WH. Total hip arthroplasty in patients with ankylosing spondylitis. Longterm followup. J Rheumatol 1995; 22:1704-9.
• 22. Camargo FP, Cordiero EN, Napoli MM. Corrective osteotomy of the spine in ankylosing spondylitis. Experience with 66 cases. Clin Orthop 1986; 208:157- 67.
• 23. Amor B, Santos RS, Nahal R, et al. Predictive factors for long term outcome of spondyloarthropathies. J Rheumatol 1994; 21:1883-7.
• 24. Glennas A, Kvien TK, Melby K, et al. Reactive arthritis. A favourable 2 year course and outcome, independent of triggering agent and HLA-B27. J Rheumatol 1994; 21:2274-80.